Excelsior Medical Co (TPE:4104) Beneish M-Score: -2.34 (As of Aug. 03, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:4104 Excelsior Medical Co Ltd TPE:4104
87 GF Score
Price NT$70.80
GF Value NT$87.68
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Excelsior Medical Co Beneish M-Score?

Excelsior Medical Co TPE:4104 -0.28% 87 Beneish M-Score is -2.34 as of Aug. 03, 2026. GuruFocus rates TPE:4104 with a GF Score™ of 87/100 and a GF Value™ of NT$87.68 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 115 Medical Distribution companies, Excelsior Medical Co ranks worse than 66.96% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.34 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Excelsior Medical Co's Beneish M-Score or its related term are showing as below:

TPE:4104' s Beneish M-Score Range Over the Past 10 Years
Min: -3.39   Med: -2.41   Max: -1.27
Current: -2.34

During the past 13 years, the highest Beneish M-Score of Excelsior Medical Co was -1.27. The lowest was -3.39. And the median was -2.41.


Excelsior Medical Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Excelsior Medical Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Excelsior Medical Co Beneish M-Score Chart

Excelsior Medical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.56 -2.35 -2.19 -2.97 -1.93

Excelsior Medical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.39 -2.46 -1.27 -1.93 -2.34

TPE:4104 vs MCK, COR, CAH: Beneish M-Score Comparison

For the Medical Distribution subindustry, Excelsior Medical Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Excelsior Medical Co Beneish M-Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Excelsior Medical Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Excelsior Medical Co's Beneish M-Score falls into.


TPE:4104
87GF Score
Excelsior Medical Co Ltd TPE:4104
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Excelsior Medical Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Excelsior Medical Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9519+0.528 * 0.9898+0.404 * 1.0279+0.892 * 1.039+0.115 * 0.9745
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.065+4.679 * 0.025946-0.327 * 0.894
=-2.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was NT$5,306 Mil.
Revenue was 2342.958 + 2280.558 + 2191.704 + 2167.649 = NT$8,983 Mil.
Gross Profit was 499.286 + 493.278 + 457.795 + 467.525 = NT$1,918 Mil.
Total Current Assets was NT$10,813 Mil.
Total Assets was NT$19,464 Mil.
Property, Plant and Equipment(Net PPE) was NT$1,024 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$311 Mil.
Selling, General, & Admin. Expense(SGA) was NT$1,182 Mil.
Total Current Liabilities was NT$6,343 Mil.
Long-Term Debt & Capital Lease Obligation was NT$680 Mil.
Net Income was 205.18 + 193.877 + 186.918 + 229.822 = NT$816 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = NT$0 Mil.
Cash Flow from Operations was 223.998 + 241.419 + -254.405 + 99.773 = NT$311 Mil.
Total Receivables was NT$5,366 Mil.
Revenue was 2149.325 + 2277.84 + 2059.156 + 2159.513 = NT$8,646 Mil.
Gross Profit was 455.773 + 509.814 + 439.564 + 422.012 = NT$1,827 Mil.
Total Current Assets was NT$10,535 Mil.
Total Assets was NT$18,758 Mil.
Property, Plant and Equipment(Net PPE) was NT$1,073 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$315 Mil.
Selling, General, & Admin. Expense(SGA) was NT$1,068 Mil.
Total Current Liabilities was NT$6,867 Mil.
Long-Term Debt & Capital Lease Obligation was NT$704 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(5306.498 / 8982.869) / (5365.553 / 8645.834)
=0.590735 / 0.620594
=0.9519

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1827.163 / 8645.834) / (1917.884 / 8982.869)
=0.211334 / 0.213505
=0.9898

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (10813.275 + 1024.06) / 19463.903) / (1 - (10535.014 + 1072.629) / 18758.386)
=0.391831 / 0.381202
=1.0279

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=8982.869 / 8645.834
=1.039

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(314.803 / (314.803 + 1072.629)) / (310.805 / (310.805 + 1024.06))
=0.226896 / 0.232836
=0.9745

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1181.667 / 8982.869) / (1067.901 / 8645.834)
=0.131547 / 0.123516
=1.065

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((680.199 + 6342.897) / 19463.903) / ((704.084 + 6866.769) / 18758.386)
=0.360827 / 0.403598
=0.894

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(815.797 - 0 - 310.785) / 19463.903
=0.025946

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Excelsior Medical Co has a M-score of -2.34 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.34 mean?
Excelsior Medical Co (TPE:4104) has a Beneish M-Score of -2.34 as of Aug. 03, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Excelsior Medical Co and its competitors. According to the industry distribution chart, Excelsior Medical Co ranks #77 out of 115 companies in the Medical Distribution industry, placing it in the top 67%.
Is Excelsior Medical Co's Beneish M-Score too high?
Excelsior Medical Co's current Beneish M-Score is -2.34. Based on the distribution chart, Excelsior Medical Co ranks #77 out of 115 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Excelsior Medical Co has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Excelsior Medical Co's Beneish M-Score compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Excelsior Medical Co ranks #77 out of 115 companies for Beneish M-Score. This places Excelsior Medical Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Distribution company?
A good Beneish M-Score depends on the Medical Distribution industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Excelsior Medical Co and its competitors. Excelsior Medical Co's current Beneish M-Score is -2.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Excelsior Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Excelsior Medical Co (TPE:4104) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$87.68, compared to a current price of NT$70.80 — trading 19.3% below its estimated fair value. The current Beneish M-Score is -2.34. Excelsior Medical Co's overall GF Score™ is 87/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Excelsior Medical Co (TPE:4104), the current Beneish M-Score is -2.34 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Excelsior Medical Co (TPE:4104) Overvalued in 2026?

Based on GuruFocus' analysis, Excelsior Medical Co stock appears to be undervalued. The current stock price of NT$70.80 is trading 19.3% below its estimated GF Value™ of NT$87.68. GuruFocus considers Excelsior Medical Co to be Modestly Undervalued.

Key valuation signals for TPE:4104:

  • Beneish M-Score: -2.34
  • GF Value™: NT$87.68 vs. price of NT$70.80 (19.3% below fair value)
  • GF Score™: 87/100 with 5 warning signs

No single metric tells the full story. See the TPE:4104 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Excelsior Medical Co Business Description

Address Zhongzheng Road, No. 880, 17th Floor, Zhonghe District, New Taipei City, TWN, 235
Excelsior Medical Co Ltd is engaged in the sale of medical supplies and medicines, home medical devices, and medical equipment with brand names of local and foreign manufacturers. Its product offerings include Fasflo hollow fiber dialyzer, Renabio sodium chloride injection, acid concentrates, Sunder blood purification tubing set, JMS blood bags, etc. The Group's reportable segments include Excelsior, Dynamic, Arich, and Others. Maximum revenue is generated from the Excelsior segment. Geographically, it derives key revenue from Taiwan and also has a presence in Hong Kong, China, the Philippines, Malaysia, and Indonesia.
87GF Score

Get the complete analysis for TPE:4104

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$70.80
Price
NT$87.68
GF Value